Boston – October 17, 2026 -- AdvaMed's The MedTech Conference, set for October 18–21, 2026, will host its largest Medtech Campus to date, with 185+ presenting companies and more than 500 speakers across Campus and education sessions. The trade body reports member participation at an all-time high and says nearly half of registered attendees are new to the event.
Keynote stage pairs device CEOs with a Wall Street analyst
Mick Farrell of Resmed, Mike Mahoney of Boston Scientific, Ashley McEvoy of Insulet and Robbie Marcus of J.P. Morgan will join a discussion moderated by John Babitt of EY. Johnson & Johnson MedTech and Operation Smile will add further perspectives.
FDA's CDRH director and CMS officials join the regulatory program
Dr. Michelle Tarver, Director of the FDA's Center for Devices and Radiological Health (CDRH), will appear alongside other senior CDRH leaders on the regulatory issues facing the sector. CMS representatives are also on the speaker roster. Sessions will address how AI and digital health are changing care, what it takes to commercialize innovation, and how companies can navigate global markets and improve patient access.
Investor programming expands with corporate reverse pitches
Leading medtech companies will outline their investment and partnering priorities through corporate reverse pitches. Attendees can book 1:1 partnering meetings before arriving. The Campus also includes live demonstrations in the Tech in Motion Hub and emerging-company pitches.
Nordic-Baltic delegation debuts as international attendance grows
Participation from Europe, the UK and Central America is strong, and a new Nordic-Baltic delegation joins this year. Dedicated programming targets students, veterans and early-career professionals.